Introduction {#S1}
============

Blood flow is necessary to sustain life through the delivery of substrates for cellular metabolism including oxygen and nutrients, and the removal of waste products. Regulation of blood flow to tissue is a complex and dynamically controlled process mediated in large part by the vascular endothelium ([@B31]). Endothelial dysfunction, the phenotypic presentation of a vasoconstricted, pro-inflammatory, thrombogenic state, underlies many diseases including atherosclerosis ([@B36]) and diabetes ([@B100]), and is present in patients with significant risk factors for cardiovascular disease including smoking ([@B62]), aging ([@B45]) and hypertension ([@B101]). A reduced bioavailability or activity of nitric oxide is thought to be the predominant mechanism underlying endothelial dysfunction, resulting in reduced vasodilation and delayed vascular reactivity ([@B19]). Other articles in this special issue will focus on the physiologic importance of mediators that maintain vascular homeostasis in the microvasculature and endothelium, but here, we briefly overview some emerging non-invasive magnetic resonance imaging (MRI) methods to evaluate peripheral vascular function in the context of injury and inflammation.

In general, assessment of endothelial function can be accomplished by measuring the magnitude and temporal dynamics of blood flow and oxygenation in response to a vasoactive stimulus such as exercise, induced ischemia, or chemical stimulation (e.g., Acetylcholine). To evaluate peripheral vascular function, a reactive hyperemia protocol is commonly used, in which the response following a period of induced ischemia is interrogated ([Figure 1](#F1){ref-type="fig"}). During the period of arterial occlusion, blood flow in the arteries, capillaries, and veins is suspended. The stagnant blood in the capillary bed is subjected to continued oxygen extraction (in short, the desaturated blood serves as an endogenous tracer), though the oxygen diffusion gradient between blood and tissue decreases as a function of ischemic duration ([@B55]). Meanwhile, there is local accumulation of vasodilators, activation of inwardly rectifying potassium channels and Na + /K + -ATPase ([@B17]), and a reduction in arteriolar pressure, causing an overall decrease in vascular resistance ([@B14]). Following cuff release, reactive hyperemia ensues with a transient surge of macrovascular flow rate as much as five-fold increase owing to the decrease in microvascular resistance downstream at the level of the arterioles. This increase of blood flow also amplify shear stress at the vessel wall, ultimately triggering additional arteriolar vasodilation ([@B88]; [@B94]). The return of blood flow causes an increase in perfusion, delivering oxygenated blood to the ischemic tissue and driving out the accumulated vasodilators and deoxygenated capillary blood. In the presence of endothelial dysfunction, the reactive hyperemia response in dampened and/or delayed ([@B29]; [@B58]; [@B56]; [@B40]). Changes in vascular reactivity may therefore provide insight into early, sub-clinical disease states ([@B28]).

![Time course oxygen saturation and blood flow over a reactive hyperemia protocol. (Top) Illustration of hemoglobin oxygen saturation (%HbO~2~) measured in the artery, proximal to the cuff (red), capillary (black dotted line), and venous (blue) circulations. During the period of ischemia, arterial and venous %HbO~2~ remain constant, but progressively decreases in the stagnant blood in the capillaries. Upon cuff release, the deoxygenated blood from the capillaries serves as an endogenous tracer and can be tracked as it flows into the large draining veins. The capillary bed and venous oxygen saturations surpass the baseline condition during hyperemia. (Bottom) Blood flow velocity and tissue perfusion decrease from the relative low baseline value to approximately zero during induced ischemia. Following cuff release, there is a transient surge in arterial flow velocity, which translates to increased perfusion, albeit at a slight lag. This figure shows the mean arterial velocity averaged over a cardiac cycle (dark red) and the real-time flow waveform (light red). The arterial flow waveform, initially triphasic at rest in healthy subjects, becomes entirely antegrade during the period of hyperemia. Dynamic, temporally resolved MRI methods can quantify various aspects of the illustrated processes. Figure adapted from [@B22] and [@B24] with permission.](fphys-11-00120-g001){#F1}

Conventional physiologic measurements used to assess surrogate markers of endothelial function include ultrasound to quantify blood flow and arterial diameter, strain gauge plethysmography to measure tissue perfusion, and invasive catheterization for blood gas analysis to determine oxygen saturation in the arteries and veins. Though commonly used clinically for evaluation of anatomy, MRI technology is far richer and has the greater potential to quantify a spectrum of physiologic parameters of interest, non-invasively across multiple vascular beds in a single session. Other imaging modalities including contrast-enhanced MRI ([@B40]; [@B102]), positron emission tomography (PET) ([@B38]), near infrared spectroscopy (NIRS) ([@B70]; [@B5]), and ultrasound ([@B15]) have also been used to evaluate peripheral vascular function. However, non-contrast MRI has the advantage of being spatially resolved (unlike plethysmography) with a fixed frame of reference (compared to NIRS or ultrasound) and is entirely non-invasive (compared to contrast-enhanced MRI or catheterization) and does not expose the subjects to ionizing radiation (in contrast to PET). Specific tailoring of the MRI pulse sequence allows for quantification of various parameters which can be expressed in physiologic units, including for instance, blood flow velocity (cm/s) or flow rate (mL/min), tissue perfusion (mL/min/100g), and oxygen saturation (% hemoglobin oxygen saturation, %HbO~2~).

Here, we review recent developments and results from quantitative, dynamic, non-contrast MRI studies for evaluation of vascular function and reactivity including blood oxygen level-dependent (BOLD) imaging, arterial spin labeling (ASL), phase contrast (PC), including MR-measured pulse wave velocity (PWV), luminal flow mediated dilation (FMD), and dynamic MR oximetry, summarized in [Table 1](#T1){ref-type="table"}. The goal of this manuscript is to introduce the reader to these MRI methods and to review studies that have employed these methods as biomarkers of disease presence, severity, and in the evaluation of treatment response.

###### 

Summary of MRI methods to dynamically evaluate vascular function.

  MR method   Measurement                             Units                     Site                                       Typical temporal resolution
  ----------- --------------------------------------- ------------------------- ------------------------------------------ -----------------------------
  BOLD        Relative capillary bed oxygen content   \% change from baseline   Microvasculature                           1--2 s
  ASL         Tissue perfusion                        mL/min/100g               Microvasculature                           2--16 s
  PC          Blood flow velocity, flow rate, PWV     cm/s or mL/min            Large arteries, veins                      5--60 ms
  FMD         Vessel diameter or area                 \% change from baseline   Large arteries                             12 s
  Oximetry    Hemoglobin oxygen saturation            %HbO~2~                   Microvasculature or large draining veins   2--228 s

BOLD, blood oxygen level-dependent; ASL, arterial spin labeling; PC, phase contrast; PWV, pulse wave velocity; FMD, flow-mediated dilation.

Bold MRI to Assess Capillary Oxygen Content {#S2}
===========================================

The most widely used MRI method to evaluate changes in blood flow and oxygenation is the measurement of the BOLD response ([@B78]; [@B42]). BOLD MRI is perhaps best known as the basis for functional neuroimaging experiments, providing insight into patterns of neural activity in response to a specified task ([@B32]). Similar principles may be applied to the peripheral circulation, allowing BOLD MRI of skeletal muscle to inform on vasoactive changes in response to exercise or induced ischemia.

The BOLD signal arises due to changes in the local content of paramagnetic deoxyhemoglobin. In the context of a reactive hyperemia paradigm, during the period of induced ischemia constant oxidative metabolism in nearby cells will cause blood in the capillary bed to desaturate, increasing the local concentration of deoxyhemoglobin. This accumulation of paramagnetic deoxyhemoglobin will cause the local magnetic field to become more inhomogeneous, ultimately leading to faster decay of the MR signal (e.g., decreased effective transverse relaxation time, T~2~^∗^). Following release of the cuff, the surge of oxygenated blood decreases the concentration of deoxyhemoglobin in the capillaries (increasing T~2~^∗^), while at the same time, expanding the blood volume, which tends to decrease T~2~^∗^. Thus, the BOLD signal serves as a surrogate marker of capillary bed oxygen content, mediated by both changes in blood flow/volume and oxygen extraction. Complicating the physiologic interpretation even more, BOLD signal is also sensitive to changes in cellular pH, vessel diameter, and vessel orientation ([@B55]; [@B18]; [@B81]; [@B73]), and is significantly impacted by static magnetic field inhomogeneities.

Despite the complicated origin of the BOLD signal, its implementation is quite straightforward. Gradient-recalled echo MR images are acquired with echo time approximately equal to the expected T~2~^∗^ (yielding T~2~^∗^- or BOLD-weighted images), or with multiple echoes to quantify T~2~^∗^ from the rate of signal decay. The dynamic data, generally measured at a temporal resolution of 1 s ([@B39]; [@B83]; [@B44]; [@B90]; [@B89]; [@B54]), are normalized by the baseline signal intensity and the relative changes in response to the vasoactive stimulus (e.g., exercise or induced ischemia) are then evaluated. The relative magnitude of the response (e.g., maximum signal change following cuff release/exercise, or minimum during induced ischemia) and the temporal response kinetics (e.g., time to half maximum/minimum, time to peak response) provide insight into the combined blood flow and oxygenation responses that are occurring locally at the level of the capillary bed.

Early manifestations of endothelial dysfunction, even in the absence of overt cardiovascular disease, have been observed with BOLD MRI. In general, those with risk factors for cardiovascular disease such as older subjects versus younger individuals ([@B83]; [@B44]) and smokers compared to non-smokers ([@B71]), demonstrated a blunting and delay of the BOLD response following induced ischemia (i.e., reactive hyperemia). In addition, impaired vascular function has been observed from BOLD imaging in clinically overt diseases including peripheral artery disease (PAD) ([@B56]; [@B23]; [@B57]; [@B6]), critical limb ischemia (CLI) ([@B39]), and systemic sclerosis ([@B74], [@B72]). Assessment of treatment response following percutaneous transluminal angioplasty in patients with CLI ([@B39]; [@B4]), showed that patients had improvements in the reactive hyperemia response as assessed by BOLD imaging. Another recent study used BOLD MRI to investigate the therapeutic effect of antioxidants on the response to exercise and induced ischemia following eccentric exercise, but contrary to their hypothesis found no significant effect ([@B54]).

These results are, in general, promising for the use of BOLD imaging during reactive hyperemia as a biomarker for disease progression and therapeutic response, particularly due to the ease of implementation. However, the BOLD response is inherently measured relative to some initial condition, is not quantified in physiologic units, and it is difficult to separate the contributions of flow and oxygenation changes to the measured signal.

ASL MRI for Perfusion Quantification {#S3}
====================================

To quantify tissue perfusion in physiologically relevant units, another type of non-contrast MRI acquisition, ASL, can be used ([@B21]; [@B96]; [@B41]; [@B43]; [@B97]). In ASL, a magnetic label (i.e., inversion pulse) is applied to water protons in arterial blood, allowing the blood, serving as an endogenous tracer, to be tracked as it flows from the large arteries into the capillary bed and perfuses the tissue. The perfusion signal is isolated by pairwise subtraction between two images, the second acquired without application of the arterial tagging pulse. The difference between these two images removes the contribution from static background tissue, leaving behind only signal related to perfusion of the labeled blood. This signal can be converted into perfusion in physiologic units of mL/min/100g through application of various models that describe the exchange of the labeled protons between arterial blood and tissue ([@B12]; [@B79]; [@B2]).

In reactive hyperemia experiments, the time course of perfusion, measured at temporal resolution up to 2 s (e.g., [@B24]) is analyzed to determine the speed (e.g., time to peak), and magnitude (e.g., peak hyperemic flow) of the post-ischemic perfusion response. Unlike BOLD, the magnitude of the response quantifies the amount of tissue perfusion, and the timing is unimpacted by the concurrent changes in capillary bed oxygen saturation. Prior studies have uncovered an association between these ASL-based measures and PAD disease presence and severity ([@B98]; [@B23]). Compared to healthy controls, patients with PAD had a decrease in peak perfusion, and with worsening disease severity, there was a prolongation of the time to peak perfusion.

In addition to the muscles of the leg, perfusion of the foot has also been interrogated ([@B104]), finding that patients with diabetes had impaired perfusion following toe extension exercise compared to healthy controls. Finally, investigation of the impact of percutaneous transluminal angioplasty with reactive hyperemia ASL measurements showed that patients with CLI had improvements in perfusion in some but not all muscles following intervention ([@B33]), which may be reflective of the heterogeneity seen between muscles prior to intervention ([@B99], [@B98]).

While ASL measures microvascular perfusion, the blood flow response in the capillary bed following induced ischemia is mediated by both the macro- and microvascular reactivity. This means that it's not possible to separate the effects from macrovascular stenoses from potential primary microvascular dysfunction. In PAD, the macrovascular lesions are generally unmodified by conservative therapies such as exercise ([@B82]), thus there is significant interest in isolating the microvascular response. Efforts to disentangle these two effects has come in the form of physiologic models of the reactive hyperemia perfusion response ([@B16]), or through simultaneous measurement of microvascular and macrovascular blood flow responses ([@B25]). Additional work to clearly define and isolate the microvascular contribution is necessary.

Phase Contrast MRI for Quantification of Macrovascular Flow {#S4}
===========================================================

In addition to quantifying perfusion in the microcirculation, MRI can also be used to measure blood flow in the large arteries and veins via PC. In PC-MRI, magnetic field gradients are used to encode the motion of the water protons into the signal phase ([@B65]; [@B10]; [@B66]). A thorough technical explanation of PC-MRI can be found in [@B68], but briefly, application of bi-polar magnetic field gradients will impart a residual phase offset in moving protons relative to static tissue as a function of velocity and gradient parameters (e.g., duration, temporal separation, and strength). Since the timing and gradient strength are chosen pulse sequence parameters, the measured phase can be converted to velocity (in cm/s).

By gating the phase contrast acquisition to the electrocardiogram, time-resolved images of blood flow throughout the cardiac cycle can be reconstructed ([@B69]). Acquisition generally takes several seconds to minutes depending on the desired apparent temporal resolution, as data are sampled over several heartbeats and synthesized together to create images over the cardiac cycle. In young healthy subjects, the baseline flow waveform of arteries in the high-resistance peripheral circulation (e.g., superficial femoral artery) is triphasic, with high velocity antegrade flow during the systolic phase of the cardiac cycle, followed by retrograde flow during early and late diastole, respectively. In contrast, patients with flow-limiting stenoses in the peripheral arteries generally have a monophasic flow waveform, attributed to decreased vascular resistance distal to the stenosis ([@B1]). In these patients, the flow profile loses the retrograde flow during diastole, remaining antegrade throughout the cardiac cycle ([@B7]; [@B63]; [@B47]; [@B92]).

Furthering this technique, velocity vector components can be resolved by encoding motion in each of the three directions in succession, and if 3-dimensional spatial encoding is implemented at the same time, 4D flow images can be reconstructed (i.e., velocity vector is time-resolved ([@B11]; [@B30]). 4D flow MRI data allow assessment of complex flow dynamics and can provide striking visualization of the impact of macrovascular lesions, showing flow jets, vortices, and areas of turbulence, which may be useful for understanding the patterns of atherosclerotic plaque development ([@B60]). Additionally, simultaneous quantification of the temporally resolved blood flow waveform at two distinct locations along the artery of interest can be used to compute PWV, a measure of arterial stiffness ([@B93]). In contrast to the traditional arterial applanation tonometry, MR-measured PWV is not limited to superficial arteries, can provide accurate path length measurements, and can probe shorter segments of the artery, providing regional PWV of the aortic arch or femoral artery ([@B51]).

In addition to this baseline characterization of the arterial flow waveform, the dynamics of the arterial blood flow response during reactive hyperemia ([@B64]; [@B49], [@B47], [@B53]) or following exercise ([@B25]) provide insight into endothelial function, vascular reactivity, and flow reserve ([@B91]). By quantifying macrovascular blood flow dynamically in the feeding artery, the time to peak flow and the duration of forward flow can be measured. These parameters are increased in the presence of PAD ([@B47]) and are sensitive to early changes in endothelial function that occur with smoking, aging ([@B53]), and have recently been shown to be acutely impaired following nicotine-free e-cigarette aerosol inhalation ([@B13]).

Flow-Mediated Dilation for Evaluation of Endothelial Function {#S5}
=============================================================

Perhaps the most widely studied surrogate marker of endothelial function is ultrasound measurements of FMD in the brachial artery following cuff-induced ischemia ([@B15]). While often regarded as an effective surrogate marker for endothelial function (or dysfunction), the method's poor intra-subject reproducibility ([@B35]) plague brachial artery FMD. The reported coefficients of variation of FMD measurements vary widely from as little as 1.5% to approximately 50% in others ([@B86]; [@B3]; [@B35]; [@B20]). This limitation is magnified since the average magnitude of FMD is approximately 5% ([@B9]) and ultrasound settings such as dynamic range, gain and probe distance are known to significantly affect diameter measurements ([@B76]). For these reasons, the value of ultrasound-based FMD measurement in routine clinical practice has been put into question ([@B8]; [@B77]; [@B84]) since its introduction over 25 years ago.

Magnetic resonance imaging (MRI) can also be used to quantify vessel cross-sectional area through a variety of measures including phase contrast angiography ([@B85]), high-resolution cine bright-blood imaging ([@B95]), and dynamic vessel wall imaging methods ([@B50]). In addition to the measurement of vessel diameter needed for FMD quantification, these MRI methods, depending on the sequence used, can be used to evaluate the vessel wall or flow dynamics. Brachial artery FMD measured by MRI was found to be lower in smokers compared to non-smokers ([@B95]), and in long-term users of birth control (contraceptive depot medroxyprogesterone acetate) during menstruation compared to control women with no intake of progestogens ([@B87]).

A new approach to rapidly acquire high-resolution vessel-wall images to assess plaque burden in PAD have been modified to quantify superficial femoral artery FMD at 60, 90, and 120 s after cuff release ([@B50], [@B46]). Of note is that the luminal FMD (denoted *FMD*~*L*~), consisting of a measurement of the change in cross-sectional area (*FMD*~*L*~≡δ*A*/*A*~*o*~≈2δ*r*/*r*~*o*~), where δ*r* and r~0~ are the changes in radius, and radius at rest, respectively, yields greater detection sensitivity compared to ultrasound-based-measurement of the change in arterial diameter, i.e., *FMD*≡δ*d*/*d*~0~ = δ*r*/*r*~*o*~. Recent work indicates that the superficial femoral artery *FMD*~*L*~ is sensitive enough to detect acute effects of nicotine-free electronic cigarette aerosol inhalation ([@B13]).

Dynamic Oximetry for Quantification of Vascular Reactivity {#S6}
==========================================================

While the previous methods generally focused on the dynamic quantification of blood flow, measurement of blood oxygen saturation (e.g., %HbO~2~) may also be useful for understanding the underlying tissue metabolism. Differences in the magnetic susceptibility of oxygenated and deoxygenated hemoglobin ([@B75]) can be exploited to quantify %HbO~2~ in the microvasculature based on the irreversible transverse relaxation time, T~2~' ([@B37]), or %HbO~2~ in large vessels via T~2~- ([@B59]) or MR susceptometry- ([@B34]; [@B26]) based oximetry. Furthermore, when these measures of oxygen extraction are combined with the previously described measures of blood flow, the muscle oxidative metabolism can be computed via Fick's principle ([@B103]; [@B61]; [@B25]).

In addition, temporally resolved measurement of intravascular venous oxygen saturation (SvO~2~) throughout an ischemia-reperfusion paradigm allows for the intravascular blood to act as an endogenous tracer as it transits from the capillary bed to the large draining vein. During the period of induced ischemia, oxygen extraction continues in the stationary blood of the capillary bed and upon cuff release, the hyperemic arterial inflow drives deoxygenated blood from the capillary bed into the collecting veins, causing the measured SvO~2~ to drop sharply ([@B48], [@B47], [@B53]; [@B52]). Thus blood flow, tissue metabolism, and endothelium-mediated dilation underlie the measured SvO~2~ dynamics measured in the large draining vein.

Washout time (time to minimum SvO~2~), upslope -- representing the rate of resaturation (maximum slope during recovery), and overshoot (peak SvO~2~ minus baseline SvO~2~) can be extracted from the SvO~2~ time course data. These metrics reflect the reactivity of the microvessels to NO-mediated vasodilation. Langham et al. revealed an association between alterations in the SvO~2~ time course-derived metrics in the femoral ([@B48]; [@B52]) or posterior tibial ([@B23]) veins and the presence of PAD. Compared to age-matched healthy controls and young healthy subjects, patients with PAD had a longer washout time, diminished upslope, and lower overshoot, suggesting endothelial dysfunction. Furthermore, these dynamic measurement of SvO~2~ are altered in pre-clinical disease states including aging and smoking ([@B53]), and most recently have been shown to be sensitive to acute effects of nicotine-free e-cig aerosol inhalation ([@B13]).

Discussion {#S7}
==========

The methods and results described herein illustrate the vast capability of MRI for dynamic evaluation of endothelial function. While there are many other approaches to quantify blood flow, arterial diameter, or oxygen saturation, MR imaging is the only modality capable of providing all parameters, non-invasively, without being limited by depth or radiation exposure. However, many of the described methods are not standard acquisition schemes available on clinical MRI scanners. Thus, there is a need for open-access to the acquisition and image analysis software packages, which would help to expand the availability of these advanced methods to researchers without dedicated MR physicists and image analysis experts.

In general, the findings reviewed herein revealed that the reactive hyperemia response was blunted and delayed in various diseases and conditions with underlying endothelial dysfunction, regardless of the measurement method, corroborating prior non-MR-based research (e.g., [@B29]). While these methods have been described in the context of investigation of peripheral vascular function, similar strategies could be used to measure cerebrovascular reactivity albeit in response to different vasoactive stimuli ([@B27]).

Use of MRI and selection of imaging contrast may ultimately help to unveil the mechanism of action for disease progression or therapeutic response. For example, it is known that exercise improves pain-limited walking distance in patients with PAD ([@B67]), but the mechanism is not entirely understood. Using MRI, changes in tissue perfusion could be used to assess the contribution of microvascular angiogenesis, while measurement of venous oxygen saturation may provide insight into changes in the mitochondrial efficiency and metabolic processes, and the combined effect of these factors may be unveiled by BOLD imaging. Finally, MR-measured perfusion, FMD, and oximetry could replace plethysmography, ultrasound, or invasive catheter-based measures for studies investigating the specific signaling pathways involved in vasodilation (e.g., [@B17]), or the effect of dietary supplements on blood flow during exercise (e.g., [@B80]).

The methods described herein have thus far been largely relegated to the realm of research. Use as a clinical tool and biomarker for disease progression and therapeutic response mandates that the accuracy, precision, and repeatability of the measurements be well documented, and that the methods be accessible on clinical scanners. Future studies combining such MRI methods with clinical measures and outcomes will help to define the additive benefit of these imaging metrics in cohorts of subjects as well as individual patients.
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